Observed arrival · 2026-11-20
Rhizome’s regulatory intelligence coworker
A life-sciences research tool that answers regulatory questions with citations from FDA, EMA, and other health-authority sources.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- Life-sciences regulatory and clinical teams
- Worth noticing
- Its displayed oncology-trial example identifies when a point rests on RAPS/DIA reporting rather than FDA guidance.
Field notes
The homepage describes an index spanning 19 countries and 122.9 million pages, and says its answers can draw on as many as 1,000 documents. These are company-reported figures, not independently verified coverage. Navigation also separates regulatory, competitive, clinical, and quality intelligence, with comparison pages for named products and general-purpose AI assistants.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
⊠LoginAccess appeared gated
$PaidCommerce or pricing visible
●ProPolished or operationally mature
◎NicheUnusually specific use
ƒJavaScriptBrowser-side code central
One card from the complete issue